Zoono Group Announces Non-Renounceable Rights Issue

Published on 2025-06-19 at 21:13

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Zoono Group Limited

Zoono Group Announces Non-Renounceable Rights Issue	06-19	RE
Zoono Group Secures Deal to Supply Shelf-Life Extension Products for Food Packaging; Shares Hit 52-Week High	05-19	MT
ASX Biggest Gainers	05-19	MT
Zoono Group Signs Exclusive UK Packaging Agreement With Sharpak Aylesham Limited, Others	05-19	RE
Zoono Group Improved Sales Revenues Expected In Q4 Fy25 And Q1 Fy26	04-29	RE
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 30, 2024	02-26	CI
Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2024	24-08-20	CI
Zoono Group Limited Auditor Raises 'Going Concern' Doubt	24-08-19	CI
Zoono Group Raises AU$500,000 via Placement	24-05-27	MT
Zoono Group Places Additional Shares to OSY Group	24-05-16	MT
Zoono Group Raises Maximum Amount Under the Rights Issue; Shares Jump 7%	24-05-08	MT
Zoono Group's Exclusive Agent OSY Signs First Major UK Client; Shares Up 18%	24-04-22	MT
Evolution Capital, OSY Group to Underwrite Zoono Group's AU$2.9 Million Rights Issue	24-03-25	MT
Zoono Group Says Unaware of Any Information for Share Price Fluctuation	24-03-19	MT
Zoono Group Signs Exclusive Deal for Sale Promotion for Products; Shares Up 8%	24-03-05	MT
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	24-02-21	CI
Zoono Group Delays Start of Up to AU$2.7 Million Rights Issue	24-01-30	MT
Zoono Group Faces Charges from the New Zealand Commerce Commission	23-12-20	MT
Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-23	CI
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI
Zoono Group Limited Announces Change of Registered Address	22-11-01	CI
Zoono Group Limited Enters into Co-Development and Licence Agreement with Douglas Pharmaceuticals	22-10-16	CI
Zoono Group Limited Develops New Nasal Spray Product	22-10-16	CI
Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-24	CI
Zoono Group Appoints CEO	22-04-01	MT